Guardion Health Sciences, Inc.
GHSI · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $12,249 | $11,050 | $7,233 | $1,890 |
| % Growth | 10.8% | 52.8% | 282.7% | – |
| Cost of Goods Sold | $6,854 | $6,529 | $4,123 | $1,947 |
| Gross Profit | $5,395 | $4,520 | $3,110 | -$57 |
| % Margin | 44% | 40.9% | 43% | -3% |
| R&D Expenses | $151 | $194 | $64 | $161 |
| G&A Expenses | $7,481 | $9,578 | $11,205 | $6,834 |
| SG&A Expenses | $9,186 | $11,648 | $13,529 | $8,285 |
| Sales & Mktg Exp. | $1,705 | $2,070 | $2,325 | $1,450 |
| Other Operating Expenses | $395 | $0 | $0 | $0 |
| Operating Expenses | $9,731 | $11,841 | $13,594 | $8,445 |
| Operating Income | -$4,336 | $433 | -$10,483 | -$8,552 |
| % Margin | -35.4% | 3.9% | -144.9% | -452.5% |
| Other Income/Exp. Net | $4,494 | $2,498 | $2 | -$20 |
| Pre-Tax Income | $158 | -$14,922 | -$24,745 | -$8,572 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $158 | -$30,277 | -$24,745 | -$8,579 |
| % Margin | 1.3% | -274% | -342.1% | -453.9% |
| EPS | 0.12 | -27.01 | -52.23 | -180.53 |
| % Growth | 100.4% | 48.3% | 71.1% | – |
| EPS Diluted | 0.12 | -27.01 | -52.23 | -180.53 |
| Weighted Avg Shares Out | 1,271 | 1,121 | 474 | 48 |
| Weighted Avg Shares Out Dil | 1,271 | 1,121 | 474 | 48 |
| Supplemental Information | – | – | – | – |
| Interest Income | $380 | $153 | $2 | $0 |
| Interest Expense | $0 | $0 | $0 | $7 |
| Depreciation & Amortization | $19 | $1,249 | $910 | $220 |
| EBITDA | -$3,922 | -$6,072 | -$9,700 | -$8,345 |
| % Margin | -32% | -55% | -134.1% | -441.6% |